CD8A and neoplasm: Tumor cells disrupt methionine metabolism in CD8+ T cells, thereby reducing intracellular levels of methionine and the methyl donor SAM and leading to loss of dimethylation at lysine 79 of histone H3 (H3K79me2), which leads to low expression of STAT5 and impaired T cell immunity (101).